Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TARA | US
0.06
1.18%
Healthcare
Biotechnology
30/06/2024
14/04/2026
5.13
5.13
5.29
5.06
Protara Therapeutics Inc. a clinical-stage biopharmaceutical company engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002 an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics Inc. and changed its name to Protara Therapeutics Inc. in May 2020. The company is headquartered in New York New York.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
58.3%1 month
53.3%3 months
85.5%6 months
89.9%-
-
0.42
0.05
0.05
0.74
-
-
-43.90M
105.83M
105.83M
-
-
-
-
-45.91
13.38
13.83
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.60
Range1M
0.69
Range3M
2.78
Rel. volume
0.88
Price X volume
3.37M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 6.12 | 113.55M | 24.90% | n/a | 571.64% |
| Dermira Inc | DERM | Biotechnology | 5.26 | 109.03M | 1.15% | 47.08 | 201.92% |
| Milestone Pharmaceuticals Inc | MIST | Biotechnology | 2.03 | 108.14M | 1.50% | n/a | 166.53% |
| Aldeyra Therapeutics Inc | ALDX | Biotechnology | 1.79 | 106.36M | -0.56% | n/a | 15.90% |
| Cellectar Biosciences Inc | CLRB | Biotechnology | 2.95 | 105.75M | 7.66% | n/a | 2.10% |
| Surrozen Inc. Common Stock | SRZN | Biotechnology | 31.85 | 102.11M | 6.66% | n/a | 35.73% |
| Agenus Inc | AGEN | Biotechnology | 4.72 | 101.82M | 13.73% | n/a | -170.56% |
| Pyxis Oncology Inc. Common Stock | PYXS | Biotechnology | 1.7 | 101.02M | -0.58% | n/a | 12.29% |
| IN8bio Inc. Common Stock | INAB | Biotechnology | 1.38 | 100.11M | 2.22% | n/a | 43.30% |
| Gossamer Bio Inc | GOSS | Biotechnology | 0.4316 | 97.64M | 7.74% | n/a | 243.93% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.41 | 98.82M | -0.81% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.06 | 98.71M | 3.59% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.98 | 75.01M | 2.45% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.6 | 65.02M | 1.12% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 14.75 | 22.46M | 41.83% | n/a | 204.46% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.91 | 13.30M | 3.42% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.623 | 12.04M | 3.83% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.32 | 3.37M | -0.75% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2149 | 2.05M | -5.58% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 1.87 | 1.03M | -9.66% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.74 | - | Expensive |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.42 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 85.46 | - | Par |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 105.83M | - | Emerging |